Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KRYS

Krystal Biotech Inc

Jun 10 • 04:00PM ET

312.41

+2.66 0.86 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM IONS ALNY INCY MDGL NUVL VKTX UTHR PCRX

| Held by: IJR VTI IWM VB XBI FBT VBK VXF SPSM IJT

Scroll to Statements

Index	RUT	P/E	41.76	EPS (ttm)	7.48	Insider Own	12.75%	Shs Outstand	29.44M	Perf Week	3.51%
Market Cap	9.21B	Forward P/E	32.17	EPS next Y	9.71	Insider Trans	-5.17%	Shs Float	25.72M	Perf Month	-0.15%
Enterprise Value	8.40B	PEG	1.39	EPS next Q	1.79	Inst Own	96.01%	Short Float	12.24%	Perf Quarter	22.51%
Income	225.03M	P/S	22.07	EPS this Y	13.33%	Inst Trans	-1.27%	Short Ratio	11.31	Perf Half Y	33.48%
Sales	417.30M	P/B	7.20	EPS next Y	25.28%	ROA	18.21%	Short Interest	3.15M	Perf YTD	26.72%
Book/sh	43.37	P/C	11.19	EPS next 5Y	23.11%	ROE	19.90%	52W High	319.48 -2.21%	Perf Year	126.04%
Cash/sh	27.93	P/FCF	38.80	EPS past 3/5Y	- -	ROIC	17.53%	52W Low	127.99 144.09%	Perf 3Y	142.33%
Dividend Est.	-	EV/EBITDA	45.31	Sales past 3/5Y	- -	Gross Margin	92.72%	Volatility	3.44% 3.48%	Perf 5Y	377.18%
Dividend TTM	-	EV/Sales	20.12	EPS Y/Y TTM	79.56%	Oper. Margin	42.81%	ATR (14)	11.02	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.06	Sales Y/Y TTM	25.15%	Profit Margin	53.92%	RSI (14)	59.94	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	9.46	EPS Q/Q	53.27%	SMA20	2.76%	Beta	0.53	Target Price	330.56
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	31.95%	SMA50	9.29%	Rel Volume	1.08	Prev Close	309.75
Employees	295	LT Debt/Eq	0.01	Earnings	May 04 BMO	SMA200	30.85%	Avg Volume	278.28K	Price	312.41
IPO	Sep 20, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.80% 3.79%	Trades		Volume	301,892	Change	0.86%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)